CU24662B1 - Compuesto de 2-feniletilamida n-(p-hidroxifenilacetil)fenilalanina como modulador de receptores transmembranas metabotrópicos e ionotrópicos - Google Patents
Compuesto de 2-feniletilamida n-(p-hidroxifenilacetil)fenilalanina como modulador de receptores transmembranas metabotrópicos e ionotrópicosInfo
- Publication number
- CU24662B1 CU24662B1 CU2020000083A CU20200083A CU24662B1 CU 24662 B1 CU24662 B1 CU 24662B1 CU 2020000083 A CU2020000083 A CU 2020000083A CU 20200083 A CU20200083 A CU 20200083A CU 24662 B1 CU24662 B1 CU 24662B1
- Authority
- CU
- Cuba
- Prior art keywords
- hydroxyphenylacetyl
- phenylalanine
- compound
- diseases
- phenythylamide
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 230000001057 ionotropic effect Effects 0.000 title 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 title 1
- 102000027257 transmembrane receptors Human genes 0.000 title 1
- 108091008578 transmembrane receptors Proteins 0.000 title 1
- 108091005462 Cation channels Proteins 0.000 abstract 1
- 206010011224 Cough Diseases 0.000 abstract 1
- 208000011231 Crohn disease Diseases 0.000 abstract 1
- 206010012438 Dermatitis atopic Diseases 0.000 abstract 1
- 206010012735 Diarrhoea Diseases 0.000 abstract 1
- 208000018522 Gastrointestinal disease Diseases 0.000 abstract 1
- 108090000862 Ion Channels Proteins 0.000 abstract 1
- 102000004310 Ion Channels Human genes 0.000 abstract 1
- 208000019693 Lung disease Diseases 0.000 abstract 1
- RAMUZNCHRXBJMG-RSAXXLAASA-N OC1=CC=C(C=C1)CC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O.C1(=CC=CC=C1)CCN Chemical compound OC1=CC=C(C=C1)CC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O.C1(=CC=CC=C1)CCN RAMUZNCHRXBJMG-RSAXXLAASA-N 0.000 abstract 1
- 108090000137 Opioid Receptors Proteins 0.000 abstract 1
- 102000003840 Opioid Receptors Human genes 0.000 abstract 1
- 206010037083 Prurigo Diseases 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 102000003610 TRPM8 Human genes 0.000 abstract 1
- 102000011040 TRPV Cation Channels Human genes 0.000 abstract 1
- 108010062740 TRPV Cation Channels Proteins 0.000 abstract 1
- 108010072901 Tachykinin Receptors Proteins 0.000 abstract 1
- 102000007124 Tachykinin Receptors Human genes 0.000 abstract 1
- 108010037150 Transient Receptor Potential Channels Proteins 0.000 abstract 1
- 102000011753 Transient Receptor Potential Channels Human genes 0.000 abstract 1
- 108050004388 Transient receptor potential cation channel subfamily V member 1 Proteins 0.000 abstract 1
- 102100029613 Transient receptor potential cation channel subfamily V member 1 Human genes 0.000 abstract 1
- 101150111302 Trpm8 gene Proteins 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 201000008937 atopic dermatitis Diseases 0.000 abstract 1
- 230000001363 autoimmune Effects 0.000 abstract 1
- 206010006451 bronchitis Diseases 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 206010009887 colitis Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 208000002551 irritable bowel syndrome Diseases 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
- 206010039083 rhinitis Diseases 0.000 abstract 1
- 230000001052 transient effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
<p>La presente invención se refiere al compuesto 2-feniletilamina N-(p-hidroxifenilacetil) fenilalanina de fórmula I</p> <p>ESPACIO PARA LA FÓRMULA</p> <p>, útil para el tratamiento de enfermedades inflamatorias y autoinmunes, tales como psoriasis, dermatitis atópica, prurigo, enfermedad de Crohn, colitis, enfermedades gastrointestinales tales como diarrea y sindrome del intestino irritable, enfermedades respiratorias tales como asma, enfermedad pulmonar crónica (COPD), bronquitis, rinitis, y también tos, así como de otras enfermedades asociadas con la actividad de receptores opioides y de taquiquinina y de canales de iones TRPV1 (canal de cationes de potencial receptor transitorio miembro 1 de la subfamilia V, también conocido como receptor de Capsaicina y receptor vanilloide 1) y TRPM8 (Canal de cationes de potencial transitorio de la subfamilia M (melastatina) miembro 8).</p>
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2018117463A RU2697414C1 (ru) | 2018-05-11 | 2018-05-11 | Новый антагонист тахикининовых рецепторов и его применение |
| PCT/RU2019/050060 WO2019216795A1 (ru) | 2018-05-11 | 2019-05-07 | Новый модулятор метаботропных и ионотропных трансмембранных рецепторов и его применение |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CU20200083A7 CU20200083A7 (es) | 2021-06-08 |
| CU24662B1 true CU24662B1 (es) | 2023-05-11 |
Family
ID=67640490
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU2020000083A CU24662B1 (es) | 2018-05-11 | 2019-05-07 | Compuesto de 2-feniletilamida n-(p-hidroxifenilacetil)fenilalanina como modulador de receptores transmembranas metabotrópicos e ionotrópicos |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US11414377B2 (es) |
| EP (1) | EP3792247A4 (es) |
| JP (1) | JP7301954B2 (es) |
| KR (1) | KR20210008061A (es) |
| CN (1) | CN112384495B (es) |
| AU (1) | AU2019267188B2 (es) |
| CA (1) | CA3099849A1 (es) |
| CL (1) | CL2020002908A1 (es) |
| CU (1) | CU24662B1 (es) |
| EA (1) | EA202092712A1 (es) |
| GE (1) | GEP20237454B (es) |
| IL (1) | IL278603B2 (es) |
| MA (1) | MA52582A (es) |
| MX (1) | MX2020012035A (es) |
| PH (1) | PH12020551928A1 (es) |
| RU (1) | RU2697414C1 (es) |
| SG (1) | SG11202011189TA (es) |
| WO (1) | WO2019216795A1 (es) |
| ZA (1) | ZA202007027B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2697414C1 (ru) * | 2018-05-11 | 2019-08-14 | Общество с ограниченной ответственностью "АЙ БИ ДИ Терапевтикс" | Новый антагонист тахикининовых рецепторов и его применение |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4579841A (en) * | 1981-07-20 | 1986-04-01 | University Patents, Inc. | Dipeptide derivatives having opiate activity |
| US5610145A (en) * | 1994-04-15 | 1997-03-11 | Warner-Lambert Company | Tachykinin antagonists |
| EA002348B1 (ru) * | 1995-02-22 | 2002-04-25 | Новартис Аг | Соединения 1-арил-2-ациламиноэтана и их применение в качестве антагонистов нейрокинина, в частности нейрокинина 1 |
| MY132550A (en) * | 1996-08-22 | 2007-10-31 | Novartis Ag | Acylaminoalkenylene-amide derivatives as nk1 and nk2 antogonists |
| GB9907571D0 (en) | 1999-04-06 | 1999-05-26 | Zeneca Ltd | Compounds |
| ES2307605T3 (es) | 2000-04-06 | 2008-12-01 | Astrazeneca Ab | Nuevos antagonistas de neuroquininas para su uso como medicamentos. |
| AU2001244999A1 (en) | 2000-04-06 | 2001-10-23 | Astrazeneca Ab | Naphthamide neurokinin antagonists for use as medicaments |
| SE0003476D0 (sv) | 2000-09-28 | 2000-09-28 | Astrazeneca Ab | Compounds |
| EP1295599A1 (en) | 2001-09-21 | 2003-03-26 | Boehringer Ingelheim International GmbH | Method for the treatment of prevention of atopic dermatitis |
| RU2309144C2 (ru) * | 2005-03-25 | 2007-10-27 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Фенилсодержащие n-ацильные производные аминов, способ их получения, фармацевтическая композиция и их применение в качестве противовоспалительных и анальгетических средств |
| CN107739316B (zh) * | 2017-11-14 | 2020-07-14 | 中国医科大学 | 一种溴代酪氨酸生物碱类化合物及其制备方法和用途 |
| RU2697414C1 (ru) * | 2018-05-11 | 2019-08-14 | Общество с ограниченной ответственностью "АЙ БИ ДИ Терапевтикс" | Новый антагонист тахикининовых рецепторов и его применение |
-
2018
- 2018-05-11 RU RU2018117463A patent/RU2697414C1/ru active
-
2019
- 2019-05-07 IL IL278603A patent/IL278603B2/en unknown
- 2019-05-07 MA MA052582A patent/MA52582A/fr unknown
- 2019-05-07 EA EA202092712A patent/EA202092712A1/ru unknown
- 2019-05-07 US US17/054,686 patent/US11414377B2/en active Active
- 2019-05-07 EP EP19799411.4A patent/EP3792247A4/en active Pending
- 2019-05-07 GE GEAP201915511A patent/GEP20237454B/en unknown
- 2019-05-07 JP JP2021513748A patent/JP7301954B2/ja active Active
- 2019-05-07 MX MX2020012035A patent/MX2020012035A/es unknown
- 2019-05-07 CN CN201980044155.6A patent/CN112384495B/zh active Active
- 2019-05-07 AU AU2019267188A patent/AU2019267188B2/en active Active
- 2019-05-07 CA CA3099849A patent/CA3099849A1/en active Pending
- 2019-05-07 KR KR1020207035511A patent/KR20210008061A/ko unknown
- 2019-05-07 CU CU2020000083A patent/CU24662B1/es unknown
- 2019-05-07 SG SG11202011189TA patent/SG11202011189TA/en unknown
- 2019-05-07 WO PCT/RU2019/050060 patent/WO2019216795A1/ru active Application Filing
-
2020
- 2020-11-09 CL CL2020002908A patent/CL2020002908A1/es unknown
- 2020-11-11 ZA ZA2020/07027A patent/ZA202007027B/en unknown
- 2020-11-11 PH PH12020551928A patent/PH12020551928A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CL2020002908A1 (es) | 2021-03-26 |
| PH12020551928A1 (en) | 2021-06-14 |
| IL278603B2 (en) | 2024-03-01 |
| CA3099849A1 (en) | 2019-11-14 |
| AU2019267188A1 (en) | 2020-11-26 |
| ZA202007027B (en) | 2022-08-31 |
| US20210070692A1 (en) | 2021-03-11 |
| IL278603A (es) | 2021-03-01 |
| MX2020012035A (es) | 2021-03-29 |
| JP7301954B2 (ja) | 2023-07-03 |
| MA52582A (fr) | 2021-03-17 |
| CU20200083A7 (es) | 2021-06-08 |
| EP3792247A4 (en) | 2022-01-12 |
| BR112020022807A2 (pt) | 2021-02-02 |
| IL278603B1 (en) | 2023-11-01 |
| SG11202011189TA (en) | 2020-12-30 |
| RU2697414C1 (ru) | 2019-08-14 |
| EA202092712A1 (ru) | 2021-02-17 |
| EP3792247A1 (en) | 2021-03-17 |
| AU2019267188B2 (en) | 2024-02-15 |
| WO2019216795A1 (ru) | 2019-11-14 |
| CN112384495B (zh) | 2023-07-18 |
| CN112384495A (zh) | 2021-02-19 |
| GEP20237454B (en) | 2023-01-10 |
| JP2021523235A (ja) | 2021-09-02 |
| US11414377B2 (en) | 2022-08-16 |
| KR20210008061A (ko) | 2021-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2020003425A1 (es) | Nuevos derivados heterocíclicos útiles como inhibidores de shp2 (divisional solicitud n° 201902698) | |
| CO2020000056A2 (es) | Nuevos compuestos y composiciones farmacéuticas de los mismos para el tratamiento de la fibrosis | |
| EA033497B1 (ru) | 1-(тиофенил или фенил)сульфонил-(пирролидин)-2-карбоксамидные производные и их применение в качестве антагонистов trpa1 | |
| CR20180029A (es) | Inhibidores peotídicos del receptor de interleucina 23 y su uso para tratar enfermedades inflamatorias | |
| CU20160160A7 (es) | Compuestos derivados de metoxibencil-pirrolopirimidin-amina como agonistas del receptor tipo toll 7 (tlr7) | |
| PA8805801A1 (es) | Agonistas novedosos de los receptores de glucorticoides | |
| MX2018008454A (es) | Derivado de amina ciclica y uso medico del mismo. | |
| PE20180482A1 (es) | Oxiesteroles y metodos de uso de los mismos | |
| MY185837A (en) | Heteroaryl syk inhibitors | |
| BR112017003975A2 (pt) | composição de conjugado de ligante e fármaco, e, composto ligador de fármaco. | |
| PH12017500974A1 (en) | Prodrugs of pehnolic trpv1 agonists | |
| BR112014019480A8 (pt) | Composto fumarato de morfolinoalquila,composição farmacêutica,e,uso dos mesmos | |
| UY35572A (es) | Nuevos agonistas del receptor de somatostatina subtipo 4 (sstr4) | |
| EA201890072A1 (ru) | Новые соединения в качестве модуляторов ror-гамма | |
| EA201691002A1 (ru) | Бициклические гетероарильные аналоги индола, подходящие в качестве модуляторов ror гамма | |
| BR112017022008A2 (pt) | composições de di-hidropiridoisoquinolinonas e composições farmacêuticas das mesmas para o tratamento de transtornos inflamatórios | |
| BR112018067312A2 (pt) | compostos e composições farmacêuticas dos mes-mos para o tratamento da fibrose | |
| EA201591204A3 (ru) | Новые хиральные n-ацил-5,6,7,(8-замещенные)-тетрагидро-[1,2,4]триазоло[4,3-а]пиразины как селективные антагонисты рецептора nk-3, фармацевтическая композиция, способы применения при нарушениях, опосредованных nk-3 рецепторами, и их хиральный синтез | |
| PA8845601A1 (es) | Antagonistas del receptor transitorio potencial de vanilloides 1(trpv1) | |
| CO2019000601A2 (es) | Derivados de oxadiazolopiridina para el uso como inhibidores de ghrelin o-aciltransferasa (goat) | |
| MX2013015274A (es) | Anatagonista trpm8 y su uso en tratamientos. | |
| BR112022006686A2 (pt) | Antagonistas de receptor muscarínico de acetilcolina m1 | |
| BR112017009595A2 (pt) | morfolina e 1,4-oxazepano amidas como agonistas do subtipo de receptor de somatostatina 4 (sstr4) | |
| AU2012357747A8 (en) | TRPM8 antagonists | |
| CU24662B1 (es) | Compuesto de 2-feniletilamida n-(p-hidroxifenilacetil)fenilalanina como modulador de receptores transmembranas metabotrópicos e ionotrópicos |